Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
Add more filters










Publication year range
1.
Rev Neurol (Paris) ; 163(3): 359-61, 2007 Mar.
Article in French | MEDLINE | ID: mdl-17404523

ABSTRACT

Adult leukoencephalopathy caused by alpha-mannosidosis deficiency (MIM248500) is a recessive inherited lysosomal storage disease associated with decreased activity of alpha-mannosidase. This enzyme degrades oligosaccharides and glycoproteins in neural and visceral tissues. There are two different disease phenotypes, type-I or severe infantile phenotype and type 2, which progresses more slowly and is compatible with survival into adulthood. We report the case of a 51-year-old man with gait disorders beginning at the age of 40 years associated with leukoencephalopathy due to alpha-mannosidosis deficiency.


Subject(s)
Cerebrovascular Disorders/etiology , alpha-Mannosidosis/diagnosis , Brain/pathology , Gait Disorders, Neurologic/etiology , Humans , Magnetic Resonance Imaging , Male , Middle Aged
2.
Comp Biochem Physiol A Mol Integr Physiol ; 129(2-3): 615-30, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11423331

ABSTRACT

Mannose-receptor-mediated clearance of circulating glycoproteins was studied in Atlantic cod (Gadus morhua). Distribution studies with radioiodinated and fluorescently labelled ligands showed that cod liver lysosomal alpha-mannosidase and yeast invertase were rapidly eliminated from blood via a mannose specific pathway in liver parenchymal cells and endocardial endothelial cells of atrium and ventricle. Asialo-orosomucoid, a galactose-terminated glycoprotein, was cleared by liver only. In vitro studies were performed with primary cultures of atrial-endocardial endothelial cells (AEC), incubated at 12 degrees C in a serum free medium. Cod AEC endocytosed mannose-terminated glycoproteins (125I-alpha-mannosidase, 125I-invertase, 125I-mannan, 125I-ovalbumin and unlabelled lysosomal alpha-mannosidase), whereas 125I-asialo-orosomucoid was not recognised. Uptake of radiolabelled mannose-terminated ligands was inhibited 80-100% in the presence of excess amounts of mannan, invertase, D-mannose, L-fucose or EGTA. Our results suggest that the cod endocardial endothelial cells express a specific Ca(2+)-dependent mannose receptor, analogous to the mannose receptor on mammalian macrophages and liver sinusoidal endothelial cells.


Subject(s)
Endocardium/metabolism , Fishes/physiology , Lysosomes/metabolism , Mannosidases/metabolism , Animals , Cells, Cultured , Endocytosis/physiology , Endothelium/cytology , Endothelium/metabolism , Female , Glycoproteins/metabolism , Glycoside Hydrolases/pharmacokinetics , Male , Mannans/pharmacokinetics , Mannosidases/isolation & purification , Ovalbumin/metabolism , Receptor, IGF Type 2/metabolism , Tissue Distribution , alpha-Mannosidase , beta-Fructofuranosidase
3.
Mol Genet Metab ; 73(1): 18-29, 2001 May.
Article in English | MEDLINE | ID: mdl-11350179

ABSTRACT

Lysosomal alpha-mannosidase (EC 3.2.1.24) is required in the degradation of the asparagine-linked carbohydrates of glycoproteins. Deficiency of this enzyme leads to the lysosomal storage disorder alpha-mannosidosis. As an initial step toward enzyme replacement therapy for alpha-mannosidosis, the human lysosomal alpha-mannosidase cDNA was cloned into the pcDNA 3.1 vector and expressed in Chinese hamster ovary cells. Dimethyl sulfoxide (DMSO) added to the cell culture media to induce growth arrest led to a 4-fold increase in the enzyme production, with an average yield of 3.2 mg L(-1) day(-1). alpha-Mannosidase was secreted as an active homodimer of a 130-kDa precursor that was proteolyzed into two polypeptides of 55 and 72 kDa during the subsequent purification of the enzyme. N-terminal sequence analysis of the purified enzyme revealed that the proteolysis occurred close to a cleavage site previously identified in the intracellular form of lysosomal alpha-mannosidase. Generation of monoclonal antibodies against the recombinant enzyme made it possible to develop a single-step immunoaffinity purification procedure for alpha-mannosidase. The immunoaffinity-purified enzyme which mainly consisted of the 130-kDa precursor, displayed specific activity and kinetics similar to those of the processed form. Recombinant alpha-mannosidase was taken up by cultured alpha-mannosidosis fibroblasts and was trafficked to the lysosomes via the mannose 6-phosphate pathway where it reduced the amounts of stored mannose-containing oligosaccharides.


Subject(s)
Mannosidases/isolation & purification , Animals , Antibodies, Monoclonal/immunology , CHO Cells , Cricetinae , Culture Media, Conditioned/chemistry , DNA, Complementary/genetics , Dimethyl Sulfoxide/pharmacology , Electrophoresis, Polyacrylamide Gel , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Gene Expression Regulation, Enzymologic , Humans , Mannosephosphates/pharmacology , Mannosidases/genetics , Mannosidases/metabolism , Mice , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Time Factors , Transfection , alpha-Mannosidase
4.
FEBS Lett ; 484(3): 175-8, 2000 Nov 10.
Article in English | MEDLINE | ID: mdl-11078873

ABSTRACT

Bovine kidney lysosomal alpha-mannosidase is a family 38 alpha-mannosidase involved in the degradation of glycoproteins. The mechanism-based reagent, 5-fluoro-beta-L-gulosyl fluoride, was used to trap a glycosyl-enzyme intermediate, thereby labelling the catalytic nucleophile of this enzyme. After proteolytic digestion and high performance liquid chromatography/tandem mass spectrometry (MS) analysis, a labelled peptide was localised, and the sequence: HIDPFGHSRE determined by fragmentation tandem MS analysis. Taking into consideration sequence alignments of this region with those of other alpha-mannosidases of the same family, this result strongly suggests that the catalytic nucleophile in this enzyme is Asp197.


Subject(s)
Aspartic Acid , Kidney/enzymology , Lysosomes/enzymology , Mannosidases/chemistry , Mannosidases/metabolism , Amino Acid Sequence , Animals , Binding Sites , Catalytic Domain , Cattle , Chromatography, High Pressure Liquid , Humans , Kinetics , Mass Spectrometry , Molecular Sequence Data , Rats , Sequence Alignment , Sequence Homology, Amino Acid , Swine , alpha-Mannosidase
5.
Hum Genet ; 104(1): 106-7, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10071201

ABSTRACT

Alpha-Mannosidosis is a lysosomal storage disorder caused by deficiency of lysosomal alpha-mannosidase (LAMAN). Major symptoms include mental retardation, skeletal changes and recurrent infections. Recently, a successful bone marrow transplantation (BMT) in an alpha-mannosidosis patient was reported. Here we show that this patient was homozygous for a novel mutation, a 1-bp insertion (1197-1198insA) in exon 9 of the LAMAN gene. By using this mutation as a marker, we demonstrate that 1 year post-BMT, the LAMAN genotype of the patient's leukocytes was identical to that of the donor. This method of genotyping blood cells is a fast and accurate way to monitor the colonization of donor bone marrow cells.


Subject(s)
Bone Marrow Transplantation , Leukocytes/enzymology , Mannosidases/deficiency , Mannosidases/genetics , Mutation/genetics , alpha-Mannosidosis/enzymology , alpha-Mannosidosis/genetics , Genetic Carrier Screening , Genotype , Humans , Polymerase Chain Reaction , Sequence Analysis, DNA , alpha-Mannosidase
6.
Am J Hum Genet ; 64(1): 77-88, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9915946

ABSTRACT

alpha-Mannosidosis is an autosomal recessive disorder caused by deficiency of lysosomal alpha-mannosidase (LAMAN). The resulting intracellular accumulation of mannose-containing oligosaccharides leads to mental retardation, hearing impairment, skeletal changes, and immunodeficiency. Recently, we reported the first alpha-mannosidosis-causing mutation affecting two Palestinian siblings. In the present study 21 novel mutations and four polymorphic amino acid positions were identified by the screening of 43 patients, from 39 families, mainly of European origin. Disease-causing mutations were identified in 72% of the alleles and included eight splicing, six missense, and three nonsense mutations, as well as two small insertions and two small deletions. In addition, Southern blot analysis indicated rearrangements in some alleles. Most mutations were private or occurred in two or three families, except for a missense mutation resulting in an R750W substitution. This mutation was found in 13 patients, from different European countries, and accounted for 21% of the disease alleles. Although there were clinical variations among the patients, no significant LAMAN activity could be detected in any of the fibroblast cultures. In addition, no correlation between the types of mutations and the clinical manifestations was evident.


Subject(s)
Mannosidases/genetics , Mutagenesis , alpha-Mannosidosis/genetics , DNA Mutational Analysis , Fibroblasts/enzymology , Humans , Molecular Sequence Data , Mutagenesis, Insertional , Mutation, Missense , Polymerase Chain Reaction , Polymorphism, Genetic , alpha-Mannosidase
7.
Genomics ; 42(2): 200-7, 1997 Jun 01.
Article in English | MEDLINE | ID: mdl-9192839

ABSTRACT

Lysosomal alpha-mannosidase (LAMAN) (EC 3.2.1.24) is an exoglycosidase involved in the ordered degradation of N-linked oligosaccharides. Lack of LAMAN activity leads to the lysosomal storage disorder alpha-mannosidosis (MIM No. 248500). We determined the genomic organization of the human lysosomal alpha-mannosidase gene (laman; HGMW-approved symbol MANB) by using oligonucleotide primers designed from the human laman cDNA sequence as part of a PCR-based strategy. The gene spanned 21.5 kb and contained 24 exons. By primer extension analysis, the major transcription initiation sites were mapped to positions -309, -196, and -191 relative to the first in-frame ATG. No CAAT or TATA sequences could be identified within 134 bp upstream of the transcription initiation sites, but the 5' flanking region contained several GC-rich regions with putative binding sites for the transcription factors SP-1, AP-2, and ETF.


Subject(s)
Genome, Human , Lysosomes/enzymology , Mannosidases/genetics , Base Sequence , Chromosome Mapping , DNA Primers/genetics , DNA, Complementary/genetics , Exons , Humans , Introns , Molecular Sequence Data , Polymerase Chain Reaction , Repetitive Sequences, Nucleic Acid , alpha-Mannosidase
8.
Eur J Biochem ; 246(2): 410-9, 1997 Jun 01.
Article in English | MEDLINE | ID: mdl-9208932

ABSTRACT

Bovine kidney lysosomal alpha-mannosidase was purified to homogeneity and the gene was cloned. The gene was organized in 24 exons that spanned 16 kb and its corresponding cDNA contained an open reading frame of 2997 bp beginning from a putative ATG start codon. The deduced amino acid sequence contained a signal peptide of 50 amino acids adjacent to a protein sequence of 949 amino acids that was cleaved into five peptides in the mature enzyme; starting with the peptide derived from the N-terminal part of this precursor, their molecular masses were 35/38 (peptide a), 11/13 (peptide b), 22 (peptide c), 38 (peptide d) and 13/15 kDa (peptide e). Variation in the degree of N-glycosylation accounts for molecular mass heterogeneities of peptides a, b and e. Peptides a, b and c were disulphide-linked. A T961-->C transition, resulting in Phe321-->Leu substitution, was identified in the cDNA of alpha-mannosidosis-affected Angus cattle. In affected Galloway cattle, a G662-->A transition that causes Arg221-->His substitution was identified. Phe321 and Arg221 are conserved among the alpha-mannosidase class-2 family, indicating that the substitutions resulted from disease-causing mutations in these breeds.


Subject(s)
Mannosidases/isolation & purification , Mutation , alpha-Mannosidosis/genetics , Amino Acid Sequence , Animals , Base Sequence , Cattle , Chromatography, Gel , Chromatography, Ion Exchange , DNA, Complementary , Electrophoresis, Polyacrylamide Gel , Exons , Mannosidases/genetics , Molecular Sequence Data , Sequence Homology, Amino Acid , Species Specificity , alpha-Mannosidase , alpha-Mannosidosis/veterinary
9.
Hum Mol Genet ; 6(5): 717-26, 1997 May.
Article in English | MEDLINE | ID: mdl-9158146

ABSTRACT

a-Mannosidosis (MIM 248500) is an autosomal recessive lysosomal storage disorder resulting from deficient activity of lysosomal alpha-mannosidase (LAMAN) (EC 3.2.1.24). The disease is characterized by massive intracellular accumulation of mannose-rich oligosaccharides with resulting mental retardation, hearing loss, immune deficiency and skeletal changes. We report here the purification and characterization of human placenta LAMAN. The enzyme is synthesized as a single-chain precursor which is processed into three glycopeptides of 70, 42 and 15 kDa. The 70 kDa peptide is further partially proteolysed into three more peptides that are joined by disulfide bridges. The laman cDNA sequence was assembled from overlapping fragments obtained by PCR on human fibroblast and human lung cDNA. The deduced amino acid sequence contains a putative signal peptide of 48 amino acids followed by a polypeptide sequence of 962 amino acids. Northern blot analyses revealed a single transcript of approximately 3.5 kb present in all tissues examined but at varying levels. Two affected siblings of Palestinian origin were homozygous for a mutation that causes a His-->Leu replacement at a position which is conserved among class 2 alpha-mannosidases from several species.


Subject(s)
Lysosomes/enzymology , Mannosidases/genetics , Mannosidases/metabolism , Mutation , alpha-Mannosidosis/genetics , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Cattle , Cloning, Molecular , Conserved Sequence , Cross Reactions , DNA, Complementary/genetics , Female , Glycopeptides/genetics , Glycopeptides/immunology , Glycopeptides/metabolism , Humans , Male , Molecular Sequence Data , Peptide Fragments/genetics , Peptide Fragments/immunology , Peptide Fragments/metabolism , Placenta/chemistry , Placenta/enzymology , Pregnancy , Protein Precursors/genetics , Protein Precursors/metabolism , Sequence Homology, Amino Acid , Tissue Distribution , alpha-Mannosidase
10.
Biochem J ; 328 ( Pt 3): 863-70, 1997 Dec 15.
Article in English | MEDLINE | ID: mdl-9396732

ABSTRACT

alpha-Mannosidosis is a lysosomal storage disorder that is caused by the deficiency of lysosomal alpha-mannosidase. Feline alpha-mannosidosis is a well-characterized animal model used for studying pathological and therapeutic aspects of lysosomal storage disorders. We here report the purification of feline liver lysosomal alpha-mannosidase and determination of its cDNA sequence. The active enzyme consisted of three polypeptides, with molecular masses of 72, 41 and 12 kDa, joined by non-covalent forces. The cDNA sequence of feline lysosomal alpha-mannosidase was determined from reverse transcriptase PCR products obtained from skin fibroblast mRNA. The deduced amino acid sequence contained the N-terminal sequences of the 72 and 41 kDa peptides. This indicated that the enzyme is synthesized as a single-chain precursor with a putative signal peptide of 50 amino acids followed by a polypeptide chain of 957 amino acids, which is cleaved into the three polypeptides of the mature enzyme. The deduced amino acid sequence was 81.1 and 83.2% identical with the human and bovine lysosomal alpha-mannosidases sequences respectively. A 4 bp deletion was identified in an alpha-mannosidosis-affected Persian cat by DNA sequencing of reverse transcriptase PCR products. The deletion resulted in a frame shift from codon 583 and premature termination at codon 645. No lysosomal alpha-mannosidase activity could be detected in the liver of this cat. A domestic long-haired cat expressing a milder alpha-mannosidosis phenotype than the Persian cat had a lysosomal alpha-mannosidase activity of 2% of normal. This domestic long-haired cat did not possess the 4 bp deletion, proving molecular heterogeneity for feline alpha-mannosidosis.


Subject(s)
Lysosomes/enzymology , Mannosidases/chemistry , Mannosidases/genetics , Mutation , alpha-Mannosidosis/genetics , Amino Acid Sequence , Animals , Base Sequence , Blotting, Western , Cats , Cattle , Cloning, Molecular , Codon , DNA Mutational Analysis , DNA, Complementary , Disease Models, Animal , Frameshift Mutation , Humans , Liver/enzymology , Mannosidases/deficiency , Mannosidases/isolation & purification , Molecular Sequence Data , Protein Conformation , Protein Processing, Post-Translational/genetics , Sequence Deletion , Sequence Homology, Nucleic Acid , alpha-Mannosidase , alpha-Mannosidosis/enzymology
11.
Res Vet Sci ; 63(3): 279-82, 1997.
Article in English | MEDLINE | ID: mdl-9491457

ABSTRACT

DNA tests, based on the polymerase chain reaction (PCR), were developed for the detection of two breed-specific mutations responsible for the autosomal recessive disorder bovine alpha-mannosidosis. The tests involve separate amplification of two exons of the lysosomal alpha-mannosidase gene followed by restriction enzyme digestion of the amplicons. We demonstrate that one of the mutations, the 662G-->A transition, is responsible for alpha-mannosidosis in Galloway cattle. The other mutation, the 961T-->C transition, is uniquely associated with alpha-mannosidosis in Angus, Murray Grey and Brangus cattle from Australia. The 961T-->C mutation was also detected in Red Angus cattle exported from Canada to Australia as embryos. All 39 animals classified as heterozygotes on the basis of biochemical assays were heterozygous for one of the two mutations. None of 102 animals classified as homozygous-normal on the basis of biochemical assays possessed the mutations. Our results indicate that the two breed-specific mutations may have arisen in Scotland and by the export of animals and germplasm disseminated to America, New Zealand and Australia.


Subject(s)
Cattle Diseases/genetics , Mannosidases/genetics , Point Mutation , alpha-Mannosidosis/veterinary , Animals , Australia , Base Sequence , Canada , Cattle , DNA Primers , Genetic Carrier Screening , Homozygote , Lysosomes/enzymology , Mannosidases/deficiency , Polymerase Chain Reaction/methods , Polymerase Chain Reaction/veterinary , Species Specificity , alpha-Mannosidase , alpha-Mannosidosis/genetics
12.
Scand J Clin Lab Invest ; 56(2): 129-34, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8743105

ABSTRACT

The mechanism by which glucose recognition of B cells results in the release of inositol 1,4,5-trisphosphate is not known at present. In pancreatic islets, fructose shares a common metabolic pathway with glucose from the second step of glycolysis and can augment insulin secretion at stimulatory glucose levels. To evaluate the impact of glycolysis on the release of inositol 1,4,5-trisphosphate, we studied the effect of glucose and fructose metabolism on insulin secretion and the activation of inositol-specific phospholipase C, using collagenase digested rat pancreatic islets incorporated with 3H-labelled myo-inositol. Inositol phosphates, generated by the cleavage of phosphatidyl inositol by inositol phospholipase C, were analyzed using fast protein liquid chromatography. The islets were exposed to 3.3, 5.5 and 12 mmol 1(-1) glucose for 45 min in the absence or presence of 10, 20 or 30 mmol 1(-1) fructose, and the amount of insulin released into the medium was measured. Intracellular inositol phosphate accumulation was measured under the same glucose concentrations with 0, 10 and 30 mmol 1(-1) fructose. As expected, fructose alone had no insulinotropic effect, but potentiated the glucose-induced (5.5 and 12 mmol 1(-1)) insulin secretion at concentrations of 10-30 mmol 1(-1). Glucose (12 vs. 3.3 mmol 1(-1)) significantly increased both intracellular content of inositol 1,4,5-trisphosphate, as well as its metabolite inositol 1,3,4-trisphosphate. Fructose, however, had no potentiating effects on the accumulation of inositol phosphates. It is therefore supposed that glucose does not activate inositol-specific phospholipase C via the glycolysis. Further, since fructose did not activate inositol-specific phospholipase C, this stimulation is likely to be induced by glucose as such.


Subject(s)
Fructose/metabolism , Inositol Phosphates/metabolism , Islets of Langerhans/metabolism , Animals , Fructose/physiology , Glucose/physiology , Insulin/metabolism , Insulin Secretion , Islets of Langerhans/chemistry , Male , Rats , Rats, Wistar
13.
Tidsskr Nor Laegeforen ; 115(5): 594-7, 1995 Feb 20.
Article in Norwegian | MEDLINE | ID: mdl-7900112

ABSTRACT

Alpha-mannosidosis is a rare autosomal recessively inherited lysosomal storage disorder. We describe three patients with alpha-mannosidosis who were born in Tromsø between 1983 and 1987, in order to increase awareness of the disease. It is characterized by a typical facial look, with a prominent forehead, hypertelorism, small nose, flat nasal bridge and hypoplastic teeth. The patients are mentally retarded, often have dysostosis multiplex, recurrent infections and typically severe loss of hearing and delayed speech development. The disease is slowly progressive in the first decade, but shows considerable clinical variability. In most cases, the lymphocytes are vacuolized, but diagnosis depends on measurement of alpha-mannosidase activity in the lymphocytes. Prenatal diagnosis is available, based on chorionic villi sampling in the 9th to 11th week of pregnancy. No causal therapy is known, but establishment of the diagnosis is important to avoid complications, recognize hearing loss and provide speech therapy and special education. The specific diagnosis is critical for genetic counselling and prenatal diagnosis. The authors therefore outline the diagnostic strategy.


Subject(s)
alpha-Mannosidosis/diagnosis , Abnormalities, Multiple/diagnosis , Abnormalities, Multiple/genetics , Child , Child, Preschool , Chorionic Villi Sampling , Diagnosis, Differential , Face/abnormalities , Female , Humans , Prenatal Diagnosis , Radiography , Spine/abnormalities , Spine/diagnostic imaging , alpha-Mannosidosis/blood , alpha-Mannosidosis/diagnostic imaging
14.
Biochem J ; 300 ( Pt 2): 541-4, 1994 Jun 01.
Article in English | MEDLINE | ID: mdl-8002961

ABSTRACT

Human lysosomal glycosylasparaginase (AGA; EC 3.5.1.26) consists of two glycosylated subunits, alpha and beta. Treatment with 3% SDS at 45 degrees C as part of a new purification scheme did not affect enzyme activity, but the alpha-subunit migrated an apparent 19 kDa peptide on SDS/PAGE instead of as a 24 kDa peptide, as observed without this SDS treatment. The N-terminal sequence was similar to that of the 24 kDa form, and, after reversed-phase h.p.l.c., the 19 kDa form was transformed to an apparent 24 kDa peptide on SDS/PAGE, indicating that their primary structures were identical. As the molecular mass of the alpha-subunit deduced from its cDNA was 19.5 kDa, the variation might be due to incomplete SDS coating of the 24 kDa form. This was confirmed by the tendency of the 24 kDa variant to polymerize even in the presence of SDS. The molecular mass of the beta-subunit was 17 and 18 kDa in accordance with previous reports. Chemical cross-linking with 1-ethyl-3-(3-dimethylaminopropyl)carbodi-imide resulted in the appearance of a 38 kDa peptide on SDS/PAGE which reacted with both the subunit-specific antisera on Western-blot analysis. On SDS/PAGE at pH 10.2 the active enzyme migrated as an apparent 43 kDa peptide. These results indicate that native human glycosylasparaginase is a heterodimer.


Subject(s)
Aspartylglucosylaminase/chemistry , Leukocytes/enzymology , Amino Acid Sequence , Aspartylglucosylaminase/isolation & purification , Chromatography, High Pressure Liquid , Electrophoresis, Polyacrylamide Gel , Humans , Macromolecular Substances , Molecular Sequence Data , Molecular Weight , Peptide Fragments/chemistry , Peptide Fragments/isolation & purification
15.
J Med Genet ; 31(5): 360-3, 1994 May.
Article in English | MEDLINE | ID: mdl-8064811

ABSTRACT

Aspartylglucosaminuria (AGU, McKusick 208400) is an autosomal recessive lysosomal storage disorder. Ninety percent of all patients are from Finland and only sporadic cases have been reported from elsewhere. In northern Norway, however, nine patients from seven families have been diagnosed with AGU. All these Norwegian patients were homozygous for the most prevalent Finnish AGU mutation (AGUFin) and show the polymorphism uniquely associated with AGUFin in Finland. Genealogical investigation of nine parents proved Finnish ancestry in all pedigrees. Therefore, AGU in Norway most likely resulted from immigration of Finnish carriers. These Finnish immigrants originated mostly from the Tornio valley area in northern Finland in a continuous immigration movement from 1700 to 1900. The majority settled in the western part of northern Norway, leading to a "cluster" of AGU in that particular area. The Finnish immigrants intermixed considerably with Lapps and these two ethnic origins should thus be considered as high risk groups for AGUFin in northern Norway.


Subject(s)
Acetylglucosamine/analogs & derivatives , Lysosomal Storage Diseases/epidemiology , Lysosomal Storage Diseases/genetics , Acetylglucosamine/urine , Adult , Aspartylglucosaminuria , Aspartylglucosylaminase/genetics , Base Sequence , DNA Primers , Female , Finland/ethnology , Genes, Recessive , Humans , Lysosomal Storage Diseases/ethnology , Male , Middle Aged , Molecular Epidemiology , Molecular Sequence Data , Norway/epidemiology , Pedigree , Point Mutation , Polymorphism, Genetic , White People
16.
Protein Expr Purif ; 5(2): 205-10, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8054856

ABSTRACT

Deficiency of human aspartylglucosaminidase (AGA, glycosylasparaginase, EC 3.5.1.26), a lysosomal amidase, results in the lysosomal storage disease aspartylglucosaminuria (AGU). This disorder is most prevalent in the genetically isolated Finnish population. To facilitate the detailed analysis of this important enzyme, which functions in the final degradation step of glycoproteins, we developed a novel purification method which makes possible a simple five-step 5000-fold purification to apparent homogeneity of human aspartylglucosaminidase from leukocytes. This purification procedure takes advantage of the remarkable SDS resistance of aspartylglucosaminidase as SDS-sensitive proteins aggregate preferentially at low (NH4)2SO4 concentrations in the presence of SDS. This new method should be applicable to the isolation of other SDS-resistant enzymes, e.g., superoxide dismutase. The homogeneous enzyme preparation exhibited a previously unreported fully denatured 19-kDa form of the alpha-subunit of aspartylglucosaminidase on SDS-polyacrylamide gel electrophoresis as a consequence of complete coating by SDS.


Subject(s)
Aspartylglucosylaminase/isolation & purification , Ammonium Sulfate , Aspartylglucosylaminase/drug effects , Chemical Precipitation , Electrophoresis, Polyacrylamide Gel , Humans , Leukocytes/enzymology , Protein Denaturation/drug effects , Sodium Dodecyl Sulfate/pharmacology
19.
EMBO J ; 12(1): 295-302, 1993 Jan.
Article in English | MEDLINE | ID: mdl-8428587

ABSTRACT

Aspartylglucosaminidase (AGA) is a lysosomal enzyme, the deficiency of which leads to a human storage disease, aspartylglucosaminuria (AGU). Although numerous mutations have been identified in AGU patients, elucidation of the molecular pathogenesis of the disease has been hampered by the missing information on the cellular events resulting in the maturation and activation of the enzyme. Here we used the expression of in vitro mutagenized constructs of the AGA cDNA to define three specific proteolytic trimming steps resulting in mature AGA. Removal of the signal peptide is immediately followed by proteolytic cleavage of the precursor into two subunits and results in biologically active enzyme already in the endoplasmic reticulum. This early activation has not previously been described for lysosomal enzymes. The subsequent lysosomal trimming does not influence the enzymatic activity of AGA. It consists only of a single proteolytic cleavage which removes 10 amino acids from the C-terminal end of the larger subunit, in contrast to the multistep lysosomal processing observed in several other hydrolases.


Subject(s)
Aspartylglucosylaminase/genetics , Aspartylglucosylaminase/metabolism , Endoplasmic Reticulum/enzymology , Lysosomes/enzymology , Protein Processing, Post-Translational , Amino Acid Sequence , Animals , Blotting, Western , Cell Line , DNA/genetics , DNA/metabolism , Diethyl Pyrocarbonate/pharmacology , Enzyme Activation , Humans , Kinetics , Macromolecular Substances , Molecular Sequence Data , Mutagenesis, Site-Directed , Polymerase Chain Reaction , Transfection
20.
Biochem J ; 282 ( Pt 3): 891-7, 1992 Mar 15.
Article in English | MEDLINE | ID: mdl-1554372

ABSTRACT

Structural and physical properties of glycosylasparaginase (EC 3.5.1.26) from the livers of human, pig, cow, rat, mouse and chicken were compared. The enzyme in all species had a common basic structure of two N-glycosylated subunits of about 24 (alpha) and 20 (beta) kDa joined by non-covalent forces. Subunit-specific antisera against the rat glycosylasparaginase bound specifically and sensitively to the corresponding subunits from all species. Identity of 80% of the amino acids was found between the N-terminal sequences of corresponding pig and rat glycosylasparaginase alpha- and beta-subunits and the deduced sequence from a human glycosylasparaginase cDNA [Fisher, Tollersrud & Aronson (1990) FEBS Lett. 269, 440-444]. The beta-subunit from all three species has an N-terminal threonine reported to be involved in the reaction mechanism for the human enzyme [Kaartinen, Williams, Tomich, Yates, Hood & Mononen (1991) J. Biol. Chem. 266, 5860-5869]. The native enzyme appeared as a heterodimer among the mammals, whereas the chicken enzyme had a greater molecular mass and is probably either a tetramer or a heterodimer bound to an unrelated peptide(s). All glycosylasparaginases were thermostable, requiring temperatures between 65 degrees C and 80 degrees C to be irreversibly inactivated. In addition, they were unusually stable at high pH and remained active in the presence of SDS except at low pH. The pH maximum was between 5.5 and 6 except for the rat and mouse enzymes which had a broad maximum between pH 7 and 8. A number of other properties were observed which also distinguish the enzyme from individual and closely related species.


Subject(s)
Aspartylglucosylaminase/chemistry , Amino Acid Sequence , Animals , Aspartylglucosylaminase/isolation & purification , Aspartylglucosylaminase/metabolism , Cattle , Chickens , Electrophoresis, Polyacrylamide Gel , Enzyme Stability , Glycosylation , Hot Temperature , Humans , Hydrogen-Ion Concentration , Immunoblotting , Isoelectric Point , Liver/enzymology , Macromolecular Substances , Mice , Molecular Sequence Data , Oxidation-Reduction , Rats , Sequence Homology, Nucleic Acid , Species Specificity , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...